A 72-year-old woman is hospitalized for a fall with a hip fracture. On postoperative day 5, she develops a urinary tract infection with fever (39.2°C), dysuria, and purulent urine. Urine culture grows a gram-negative rod that is oxidase-positive. The organism produces a fruity odor and is resistant to multiple β-lactams. What is the most appropriate initial antibiotic therapy, and what is the mechanism of the fruity odor production?

Explanation

## Diagnosis: Pseudomonas aeruginosa UTI **Key Point:** The clinical clues pointing to *Pseudomonas aeruginosa* are: - **Oxidase-positive** gram-negative rod - **Fruity/grape-like odor** (classic bedside clue for *P. aeruginosa*) - **Multi-β-lactam resistance** (AmpC β-lactamase, efflux pumps, porin loss) - **Postoperative nosocomial UTI** in an elderly, hospitalized patient --- ### Most Appropriate Initial Antibiotic Therapy **Clinical Pearl:** For *P. aeruginosa* UTI, the preferred initial antibiotic is a **fluoroquinolone (ciprofloxacin)**, not an aminoglycoside, for the following reasons: | Agent | Urinary Penetration | Oral Bioavailability | Nephrotoxicity Risk | Notes | |-------|--------------------|--------------------|-------------------|-------| | Ciprofloxacin | Excellent | ~80% | Low | First-line for *P. aeruginosa* UTI | | Gentamicin | Good | IV/IM only | High (requires monitoring) | Reserved for synergy or when quinolones fail | | Meropenem | Good | IV only | Low | Reserved for extensively resistant strains | | Ceftazidime | Moderate | IV only | Low | Anti-pseudomonal but not first-line for UTI | Ciprofloxacin achieves very high urinary concentrations, is available in oral and IV formulations, and avoids the nephrotoxicity and ototoxicity risks of aminoglycosides — particularly important in a 72-year-old patient. Per Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (9e, Ch. 230), fluoroquinolones are the preferred oral agents for *P. aeruginosa* UTI when susceptibility is confirmed. --- ### Mechanism of the Fruity Odor **High-Yield:** The characteristic fruity/grape-like odor of *P. aeruginosa* is produced by **phenazine pigments** — secondary metabolites synthesized via the phenazine biosynthetic pathway. The key pigments include: | Pigment | Color | Role | |---------|-------|------| | Pyocyanin | Blue-green | Redox-active virulence factor, electron shuttle | | Pyoverdine | Yellow-green | Siderophore for iron acquisition | | Phenazine-1-carboxylic acid | Yellow | Precursor to pyocyanin | These pigments are regulated by **quorum sensing** (las and rhl systems) and are produced as secondary metabolites — NOT from acetyl-CoA metabolism producing acetone/ethyl acetate (option D's mechanism is incorrect). The odor is a direct result of volatile phenazine derivatives released during bacterial growth. > **Note on Option A:** While pyocyanin IS a phenazine pigment and does participate in quorum-sensing signaling, attributing the odor solely to "pyocyanin as a quorum-sensing signal" is mechanistically imprecise. The odor arises from the broader class of **phenazine pigment synthesis as secondary metabolites** — which is the description in option D. Furthermore, option A pairs this with carbapenems, which are not the most appropriate *initial* therapy for a UTI (reserved for extensively resistant infections). **Option D** correctly identifies both the most appropriate initial antibiotic (ciprofloxacin/fluoroquinolone) AND the correct mechanism of odor production (phenazine pigment synthesis as secondary metabolites via the phenazine biosynthetic pathway). [cite: Jawetz, Melnick & Adelberg's Medical Microbiology 28e, Ch. 21; Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 9e, Ch. 230; KD Tripathi Essentials of Medical Pharmacology 8e]